Clinical Trial Update: A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Completed Phase 2 multicenter study assessing high-dose chemotherapy with autologous stem cell transplant followed by romidepsin maintenance in T-cell non-Hodgk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Non-hodgkin Lymphoma

Drugs mentioned

• Romidepsin (romidepsin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: T Cell Non-Hodgkin Lymphoma | Phase 2 | Status: COMPLETED